MedPath

甘肃佛仁制药科技有限公司

Ownership
-
Established
2004-03-29
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

46

NMPA:46

Drug Approvals

补中益气丸

Approval Number
国药准字Z62020689
Approval Date
Aug 9, 2024
NMPA

健脾丸

Approval Number
国药准字Z62020892
Approval Date
Aug 9, 2024
NMPA

参苓白术散

Approval Number
国药准字Z62020693
Approval Date
Aug 9, 2024
NMPA

大山楂丸

Approval Number
国药准字Z62020695
Approval Date
Aug 9, 2024
NMPA

归脾丸

Approval Number
国药准字Z62020704
Approval Date
Aug 9, 2024
NMPA

橘红丸

Approval Number
国药准字Z62020909
Approval Date
Aug 9, 2024
NMPA

参芪膏

Approval Number
国药准字Z62020691
Approval Date
Aug 9, 2024
NMPA

加味藿香正气丸

Approval Number
国药准字Z62020907
Approval Date
Aug 9, 2024
NMPA

百合固金丸

Approval Number
国药准字Z62020687
Approval Date
Aug 9, 2024
NMPA

九味羌活丸

Approval Number
国药准字Z62020893
Approval Date
Aug 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.